{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-006901","form_type":"8-K","ticker":"LCTX","cik":"0000876343","company_name":"Lineage Cell Therapeutics, Inc.","filed_at":"2024-02-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.107493+00:00","generated_at":"2026-06-06T01:46:12.322082+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Annual meeting set for June 11, 2024; shareholder proposal deadlines announced","bullets":["2024 annual meeting of shareholders scheduled for June 11, 2024.","Shareholder business or director nominations due by March 15, 2024.","Shareholder proposals for proxy statement inclusion due by March 29, 2024.","Notices directed to Corporate Secretary at Carlsbad, CA address."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-006901","json":"https://secwatch.observer/filing/0001493152-24-006901.json","markdown":"https://secwatch.observer/filing/0001493152-24-006901.md","text":"https://secwatch.observer/filing/0001493152-24-006901.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/876343/000149315224006901/0001493152-24-006901-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/876343/000149315224006901/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T01:46:12.322082+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}